As of 2026-03-31, North China Pharma（华北制药）'s data on the DeepSeek platform in the 水溶性维生素 category shows: The overall mention rate is 0.00%, below the industry average by 1.5 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, North China Pharma（华北制药）'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
North China Pharma（华北制药）'s Mention Rate is 0.00%, lower than 0.6% of competitors
North China Pharma（华北制药）'s First Mention is 0.00%, lower than 0.9% of competitors
North China Pharma（华北制药）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
North China Pharma（华北制药）'s Positive Rate is 0.00%, lower than 8.9% of competitors
North China Pharma（华北制药）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| PPfizer（辉瑞） | 3.77% | 3.77% | 0% | 1.89% | 0% | View Details |
| DDSM（帝斯曼） | 3.77% | 0% | 0% | 1.89% | 0% | View Details |
| BBASF（巴斯夫） | 3.77% | 0% | 0% | 1.89% | 0% | View Details |
| DDuPont（杜邦） | 3.77% | 0% | 0% | 1.89% | 0% | View Details |
| ZZhejiang Medicine（浙江医药） | 0% | 0% | 0% | 0% | 0% | View Details |
| CCSPC（石药集团） | 0% | 0% | 0% | 0% | 0% | View Details |
| NNorth China Pharma（华北制药） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
